Robert V Holton, III
Co-Founder & COO
Robert V. Holton, III has over 20 years of experience turning mid-stage companies into profitable enterprises. During his time as a venture capitalist, Rob raised over $300 million in private equity, helping launch over 25 companies. As Co-founder and COO of BASE10 Genetics, he's created a business model that effectively operates within the intersection of transformational health outcomes and positive payor ROI. Rob's business expertise and BASE10's proprietary technology platforms have brought to market novel disease management solutions for diabetes and the COVID-19 pandemic. Robert's personal journey with precision medicine resulted in the successful conception of his two beautiful daughters. Inspiring and prompting him to bring the power of genomic-based medicine to those individuals who most need it.